Acorda Therapeutics Announces Completion of One-for-Six Reverse Stock Split itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.
SAP’s subsidiary Qualtrics International Inc. files for an IPO in the U.S.
Qualtrics reports a 32% growth in total revenue to £408.12 million.
MYT Netherlands parent B.V also files for a U.S. IPO on Monday.
German SAP-owned Qualtrics International Inc. said late on Monday that it had filed for an IPO in the United States valued at up to £74.20 million. SAP SE (ETR: SAP) acquired the U.S. based technological services provider in 2018 for £5.94 billion.
Qualtrics reports a 32% growth in revenue to £408.12 million
The regulatory filing on Monday highlighted that SAP America Inc. will have a controlling stake in Qualtrics, owning all of its Class B shares (423.2 million) after the initial public offering. As per the company, Qualtrics also intends to have its Class A common stock listed under the symbol “XM” on the Nasdaq Global Select Market. The company forecasts to price its shares between £14.84 and £17.81 in its IPO.
Assertio Announces Transfer of Listing from Nasdaq Global Select Market to Nasdaq Capital Market tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Nanobiotix Announces Closing of Underwriters Option to Purchase Additional ADSs NANOBIOTIX (Paris:NANO) (Euronext: NANO Nasdaq: NBTX the
Company ), a clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced the closing of an additional 1,095,000 American Depositary Shares (
ADSs ) pursuant to the full exercise of the underwriters option to purchase additional ADSs in connection with the Company s initial public offering on the Nasdaq Global Select Market.
The 1,095,000 additional ADSs were sold at $13.50 per ADS, the same public offering price as in the initial public offering. Consequently, the total number of ordinary shares issued amounts to 8,395,000, including 6,540,000 in the form of ADSs, and the total net proceeds (including the sale of the additional ADSs pursuant to the exercise of the underwriters option), after deducting underwriting commissions and estimated offering expenses payable by Nanobiotix, from th
Share this article
Share this article
NEW YORK, Dec. 15, 2020 /PRNewswire/ American Finance Trust, Inc. (Nasdaq: AFIN) ( AFIN or the Company ) today announced the pricing of an underwritten public offering of 3,200,000 shares of its 7.375% Series C Cumulative Redeemable Perpetual Preferred Stock (the Series C Preferred Stock ) at a gross offering price of $25.00 per share. In addition, the Company has granted the underwriters a 30-day overallotment option to purchase up to an additional 480,000 shares of Series C Preferred Stock. The Company has applied to list the shares of Series C Preferred Stock on the Nasdaq Global Select Market. The Series C Preferred Stock will have a $25.00 liquidation preference per share.